Lung Biorepository

Overview

About this study

To create a biorepository of fluid [lung lavage], blood and tissue specimens [explanted diseased lung tissue from the recipient and serial lung biopsy specimens after transplant] for future studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Eligibility criteria, including the population(s) from which specimens/data will be obtained: 

All patients with advanced end-stage lung and heart-lung disease deemed suitable for lung or combined heart-lung [or at times lung-liver, lung kidney etc., where lung is one of the failed organs] transplantation, once actively listed for lung or combined heart-lung, lung-kidney or liver-lung transplantation will be eligible.

Provisions for inclusion of minorities: 

All adult patients over age 16 years, who meet the above mentioned criteria, will be approached for study participation, regardless of race or sex or other indicator of minority status.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ramachandra Sista, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions